SC
MDT icon

Scotia Capital’s Medtronic MDT Stock Holding History

Scotia Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-30,000
Closed -$2.25M – 743
2016
Q1 		$2.25M Buy
+30,000
New +$2.26M 0.05% 225

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Scotia Capital's MDT Position: Q1 2026 in Review

Scotia Capital increased its Medtronic (MDT) stake by 0.62% in Q1 2026, buying an estimated $512K and bringing the position to 873,375 shares worth $75.7M. The position accounts for 0.31% of the portfolio, ranked #60.

Scotia Capital first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $94.9M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Scotia Capital held 873,375 shares of Medtronic worth $75.7M as of Q1 2026.
  • Scotia Capital bought 5,341 Medtronic shares in Q1 2026, an estimated $512K.
  • Medtronic made up 0.31% of Scotia Capital's portfolio in Q1 2026, its #60 holding.
  • Scotia Capital first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Scotia Capital's Medtronic position peaked at $94.9M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.